00000nam 2200000zi 4500 9.931311 CaOODSP 20240201105620 m o d f cr mn||||||||| 231211t20242023onc ob f000 0 eng d 9780660692654 (report) 9780660692661 (summary) CaOODSP eng rda CaOODSP n-cn--- HP5-176/1-2024E-PDF HP5-176/2-2024E-PDF Guidance on an additional dose of COVID-19 vaccines in the spring of 2024 for individuals at high risk of severe illness due to COVID-19. Ottawa, ON : Public Health Agency of Canada = Agence de la santé publique du Canada, January 12, 2024. ©2023 1 online resource (13 unnumbered pages) + 1 summary (5 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in French under title: Directives sur l'administration d'une dose supplémentaire de vaccins contre la COVID-19 au printemps 2024 pour les personnes exposées à un risque élevé de maladie sévère en raison de la COVID-19. At head of title: "An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)." Includes bibliographical references. COVID-19 (Disease) Vaccination Government policy Canada. COVID-19 vaccines Government policy Canada. Public Health Agency of Canada, issuing body. Canada. National Advisory Committee on Immunization, issuing body. Directives sur l'administration d'une dose supplémentaire de vaccins contre la COVID-19 au printemps 2024 pour les personnes exposées à un risque élevé de maladie sévère en raison de la COVID-19. (CaOODSP)9.931313 PDF 561 KB https://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-176-1-2024-eng.pdf Guidance PDF KB https://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-176-2-2024-eng.pdf Summary 230641 (Guidance) 230643 (Summary)